American Society of Plastic Surgeons
For Consumers
 

Tiger Aesthetics leaders to host webinars, Q&A sessions on future of Sientra breast implants

Tiger Aesthetics Medical, LLC, the company that acquired Sientra's breast implant business on April 24, announced that it will host webinars on May 28 and June 6 to give plastic surgeons an opportunity to ask questions and learn more about the company.

In a letter to ASPS members from Oliver Burckhardt and Scott Madden, co-CEOs of Tiger Aesthetics, the company addressed several key concerns related to the transition, including a confirmation that the Sientra warranty will continue to be honored.

Click here to view the letter in its entirely.

"The Platinum20® warranty remains unchanged," the letter states. "With our unwavering confidence in Sientra implants' unrivaled safety profile, Tiger Aesthetics will honor and continue to offer the same Sientra 20-year warranty for all gel implants at no cost to you or your patients. This will allow our customers to provide Sientra gel implant patients with the industry's longest and most comprehensive warranty. As part of this commitment to patients, we have assumed warranty obligations for ALL Sientra patients, both pre-and-post acquisition."

The letter also notes that Tiger Aesthetics remains committed to Sientra's customers and will honor all properly reconciled and legitimate customer credits.

"We are working diligently to address any and all reconciled and legitimate credits with our customers," the letter states.

Click here for information on the webinars.

Tiger Aesthetics says that orders can continue to be placed through local Sientra sales representatives, or by contacting (888) 788-0808 or customer.experience@sientra.com.

ASPS members with questions are concerns are encouraged to contact the Tiger Aesthetics co-CEOs directly at oliverb@tigerbios.com or scottm@tigerbios.com.

UPDATE: The webinar originally scheduled for June 4 has been moved to June 6. Our article has been updated above to reflect this change, but the original letter from the co-CEOs that is linked to has not been updated.